GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020

Rhea-AI Summary

GenMark Diagnostics (NASDAQ: GNMK) plans to release its third quarter earnings results on October 28, 2020, after market close. A conference call will take place at 1:30 p.m. PT / 4:30 p.m. ET to discuss financial performance. The call will be available via webcast on GenMark's website, and interested parties can join by calling designated numbers with a conference ID. GenMark specializes in multiplex molecular diagnostic solutions, enhancing patient care and reducing costs through its eSensor technology.

Positive

• GenMark's ePlex system addresses a wide range of infectious disease testing needs, supporting growth potential.
• The upcoming earnings release indicates ongoing financial transparency and engagement with investors.

Negative

• None.

CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, October 28, 2020. Management will hold a conference call to review the company's financial performance starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast.

The link to the webcast will be available on the GenMark Diagnostics, Inc. website at www.genmarkdx.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number 2955234 approximately ten minutes prior to the start time.

ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com

FAQ

When will GenMark Diagnostics release its third quarter earnings?

GenMark Diagnostics will release its third quarter earnings on October 28, 2020.

What time is the GenMark Diagnostics conference call?

The conference call will start at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on October 28, 2020.

How can I listen to the GenMark Diagnostics conference call?

You can listen by dialing (877) 312-5847 for US/Canada or (253) 237-1154 for international callers using conference ID 2955234.

What is GenMark Diagnostics known for?

GenMark Diagnostics is known for providing multiplex molecular diagnostic solutions that enhance patient care and reduce the total cost of care.